Amazon Brings AI Expertise to Drug Industry in Novartis Pact
(Bloomberg) -- Amazon.com Inc. is teaming up with one of the world's biggest pharmaceutical companies to make the manufacturing and delivery of new medicines more efficient.
Seattle-based Amazon's cloud-computing unit will work with Novartis AG to help the Swiss drugmaker forecast and track production, detect potential bottlenecks and monitor its sprawling operations in real time, the companies said in a statement Wednesday. The partners didn't disclose financial terms.
The pact is the latest sign of the tech industry's push into health care, with Amazon, Microsoft Corp. and Google parent Alphabet Inc. keen to bring their cloud services to the fast-growing field. Amazon has partnered with Berkshire Hathaway Inc. and JPMorgan Chase & Co. on an employee-health venture and bought online pharmacy PillPack last year.
Cerner Corp., a software supplier to the health-care industry, said this week that it will rely on Amazon's artificial intelligence and machine-learning expertise to develop programs that can predict medical diagnoses or recommend treatment. The internet giant said in March that its Amazon Web Services unit would work with a Harvard-affiliated teaching hospital in Boston to test how AI can simplify medical care.
The new collaboration with Novartis harnesses Amazon's AI skills and is part of the Basel, Switzerland-based drugmaker's effort to accelerate delivery of medicines. Novartis will look at extending the technology to areas beyond manufacturing, said Chief Digital Officer Bertrand Bodson, a veteran of Amazon and other retailers who joined Novartis last year.
The partnership will also allow Novartis to improve inspections of manufacturing sites by analyzing images using computer algorithms and to monitor risks such as unplanned downtime or delayed orders. It follows an AI agreement that Novartis signed with Microsoft in October.
To contact the reporter on this story: James Paton in London at jpaton4@bloomberg.net
To contact the editors responsible for this story: Eric Pfanner at epfanner1@bloomberg.net, Anne Pollak, John Lauerman
©2019 Bloomberg L.P.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
